WILSHIRE, JOHN F. K., AUSTRAL. J. CHEM., 41,(1988) N 6, C. 995-1001
作者:WILSHIRE, JOHN F. K.
DOI:——
日期:——
Fused Ring Diarylamino Photosensitizers for Phototherapy
申请人:Rajagopalan Raghavan
公开号:US20120289884A1
公开(公告)日:2012-11-15
The invention relates generally to optical agents and methods of using optical agents for biomedical applications, including phototherapy. Provided are methods of using diarylamino compounds having a fused ring backbone providing phototherapeutic agents, including Type 1 phototherapeutic agents. Optical agents of the invention enable a versatile phototherapy platform for treatment of a range of pathological conditions, including the treatment of cancers, stenosis and inflammation. The invention further provides preparations and formulations comprising the diarylamino optical agents and related methods of making and using diarylamino optical agents in an in vivo or ex vivo biomedical procedure.
Wilshire, John F. K., Australian Journal of Chemistry, 1988, vol. 41, # 6, p. 995 - 1001
作者:Wilshire, John F. K.
DOI:——
日期:——
Type 1 Phototherapeutic Agents, Part I: Preparation and Cancer Cell Viability Studies of Novel Photolabile Sulfenamides
作者:Amolkumar S. Karwa、Amruta R. Poreddy、Bethel Asmelash、Tien-Sung Lin、Richard B. Dorshow、Raghavan Rajagopalan
DOI:10.1021/ml2001483
日期:2011.11.10
Novel type 1 phototherapeutic agents based on compounds containing S–N bonds (sulfenamides) were synthesized, assessed for free radical generation, and evaluated in vitro for cell death efficacy in four cancer cell lines (U937, HTC11, KB, and HT29). All of the compounds were found to produce copious free radicals upon photoexcitation with UV-A and/or UV-B light, as determined by electron spin resonance